FDA-approved medications such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are proprietary to Novo Nordisk™, while Mounjaro® and Zepbound™ are products of Eli Lilly and Company™. This website is not affiliated with, endorsed by, or connected in any way to these companies or their products.

When clinically appropriate and prescribed by a licensed healthcare provider, patients may receive either FDA-approved medications or compounded medications, depending on individual medical evaluation and treatment considerations.

Compounded medications are prepared by licensed pharmacies pursuant to a patient-specific prescription in accordance with applicable federal and state law, including Section 503A of the Federal Food, Drug, and Cosmetic Act.

Compounded drugs are not FDA-approved. They do not undergo FDA premarket review for safety, effectiveness, or manufacturing quality. Compounded medications may be prescribed when a licensed provider determines they are clinically appropriate for an individual patient.